Since the landmark studies of Patel and Terasaki pretransplant identification of donor-directed HLA alloantibodies DSAs has been a critical prelude to renal allograft transplantation. Pretransplant DSAs may be an acceptable risk or an unconditional contraindication to transplantation depending on the particular donor\u200a:\u200arecipient combination. Posttransplant DSAs are associated with episodes of acute rejection chronic rejection and graft loss. Thus monitoring for such antibodies is an important aspect of patient care. Technical aspects of HLA antibody testing.